Life Sciences in Limbo: The Funding Frenzy
The life sciences industry is currently in a state of uncertainty. This is due to a recent decision by the federal government to reduce funding for research institutions. The National Institutes of Health announced in early February that it would limit funding for indirect costs to 15%. These costs